Nastaran Namazi

Shahid Beheshti University of Medical Sciences, Teheran, Tehrān, Iran

Are you Nastaran Namazi?

Claim your profile

Publications (5)8.69 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Prolactin (PRL) level is proposed to be associated with the severity of psoriasis although the previous studies reported different results. Objective. To find the association between PRL levels and severity of psoriasis before and after treatment. In addition, we aimed to find a difference in prolactin, thyroid stimulating hormone (TSH), thyroid hormones (T3 and T4), and cortisol levels between patients with psoriasis and normal controls. Methods. First, the levels of hormones were measured in 30 patients with psoriasis and 30 matched controls. The severity was assessed by psoriasis area and severity index (PASI). Then, patients were treated, and PASI was assessed every week until achieving PASI-75 response. At this time, the hormones were measured again and compared to the baseline. Results. No statistical significant difference was observed in the mean PRL, T3, T4, TSH, and cortisol levels between cases and controls. Comparing to the baseline, a significant decrease in PRL levels and a significant increase in T3 and serum cortisol levels were observed after treatment (P < 0.05), while the changes in other hormones were not significant. Conclusion. After treatment, PRL significantly decreased, and T3 and cortisol levels significantly increased. No correlation between hormone levels and improvement of PASI score existed.
    The Scientific World Journal 10/2013; 2013(2):921819. DOI:10.1155/2013/921819 · 1.73 Impact Factor
  • Journal of the European Academy of Dermatology and Venereology 09/2012; · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Promoter polymorphisms of the macrophage migration inhibitory factor gene are associated with increased production of macrophage migration inhibitory factor. Elevated levels of macrophage migration inhibitory factor have been observed in the sera of patients with pemphigus vulgaris. More than this, macrophage migration inhibitory factor promoter gene polymorphism has been found to confer increased risk of susceptibility to chronic inflammatory diseases. Objective We investigated whether there is an association between promoter polymorphism of the macrophage migration inhibitory factor gene and pemphigus vulgaris. Methods One hundred and six patients with pemphigus vulgaris, and a control panel of one hundred healthy volunteers were genotyped for a single nucleotide polymorphism identified in the 5'-flanking region at the position -173 of the gene, using polymerase chain reaction-restriction fragment length analysis. Results We found a notably high prevalence of C/C genotype in our nation but no significant difference was observed between patients and controls. Conclusion The result of this study using a large and well documented trial of patients showed that macrophage migration inhibitory factor -173G-C polymorphism is not associated with pemphigus vulgaris; but as the role of macrophage migration inhibitory factor in the inflammatory process has not been delineated in detail and the prevalence of C/C genotype is notably higher in our nation, this finding merits more consideration.
    Journal of the European Academy of Dermatology and Venereology 08/2012; DOI:10.1111/j.1468-3083.2012.04676.x · 2.83 Impact Factor
  • Parviz Toossi · Zahra Asadi Kani · Mehdi Qeisari · Nastaran Namazi
    International journal of dermatology 07/2012; 51(7):877-8. DOI:10.1111/j.1365-4632.2010.04717.x · 1.31 Impact Factor
  • Parviz Toosi · Zahra Asadi Kani · Mehdi Qeisari · Nastaran Namazi
    01/2011; 02(04). DOI:10.4172/2155-9554.1000124